Purple Biotech (PPBT) Receivables - Other (2014 - 2024)

Purple Biotech (PPBT) reported Receivables - Other of $1000.0 for Q4 2024, little changed year-over-year from $1000.0 in Q1 2024, and little changed quarter-over-quarter from $1000.0 in Q4 2023.

Purple Biotech (PPBT) Receivables - Other (2014 - 2024) Analysis & Trends

Purple Biotech (PPBT) has 7 years of Receivables - Other data on file, last reported at $1000.0 in Q4 2024.

  • Receivables - Other for Q4 2024 came in at $1000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $1000.0 (changed 0.0% YoY), and the FY2024 annual result was $1000.0, changed 0.0% from the prior year.
  • Receivables - Other held at $1000.0 in Q4 2024 per PPBT's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $6000.0 in Q4 2021 and troughed at $1000.0 in Q4 2023.
  • A 3-year average of $2666.7 and a median of $1000.0 in 2023 frame the typical range for Receivables - Other.
  • On a YoY basis, Receivables - Other climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
  • A 3-year view of Receivables - Other shows it stood at $6000.0 in 2021, then tumbled by 83.33% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Business Quant data shows PPBT's Receivables - Other at $1000.0 in Q4 2024, $1000.0 in Q4 2023, and $6000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Purple Biotech 261.30 Mn 254.88 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Dec 31, 2021 6,000.00
Dec 31, 2021 6,000.00
Dec 31, 2017 590,000.00
Dec 31, 2017 590,000.00
Jun 30, 2017 762,000.00
Jun 30, 2017 762,000.00
Dec 31, 2016 241,000.00
Dec 31, 2016 241,000.00
Jun 30, 2016 644,000.00
Jun 30, 2016 644,000.00
Dec 31, 2015 246,000.00
Dec 31, 2015 246,000.00
Sep 30, 2015 553,000.00
Sep 30, 2015 553,000.00
Dec 31, 2014 446,000.00
Dec 31, 2014 446,000.00